ValuEngine lowered shares of Bioamber (NYSE:BIOA) from a sell rating to a strong sell rating in a report issued on Friday.
Several other brokerages have also issued reports on BIOA. HC Wainwright reaffirmed a buy rating and set a $12.00 price target on shares of Bioamber in a research note on Wednesday, November 8th. Cowen reaffirmed a hold rating and set a $1.00 price target on shares of Bioamber in a research note on Friday, November 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the stock. Bioamber presently has an average rating of Hold and an average price target of $6.50.
Shares of Bioamber (NYSE BIOA) traded down $0.02 on Friday, hitting $0.42. The stock had a trading volume of 938,700 shares, compared to its average volume of 948,388. The company has a current ratio of 1.08, a quick ratio of 0.75 and a debt-to-equity ratio of 0.24. Bioamber has a twelve month low of $0.32 and a twelve month high of $6.24.
TRADEMARK VIOLATION NOTICE: “Bioamber (BIOA) Downgraded by ValuEngine” was first published by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this news story can be read at https://www.com-unik.info/2017/12/04/bioamber-bioa-downgraded-by-valuengine.html.
Bioamber Company Profile
BioAmber Inc (BioAmber), formerly DNP Green Technology, Inc, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products.
To view ValuEngine’s full report, visit ValuEngine’s official website.
What are top analysts saying about Bioamber Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Bioamber Inc and related companies.